Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camilo Jimenez

Showing results (61-70 of 146) with videos related to

Pageof 15
Sort By:
Archives of Endocrinology and Metabolism|May 25, 2021
Ectopic Cushing syndrome in ColombiaVanessa Lopez-Montoya, Johnayro Gutierrez-Restrepo, Jose Luis Torres Grajales, et al.
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|January 23, 2018
Calcitriol-mediated hypercalcemia secondary to granulomatous disease caused by soft-tissue filler injection: a case reportJairo Arturo Noreña, César Daniel Niño, Sabrina Gallego, et al.
World Journal of Surgery|January 27, 2012
Preoperative serum osteocalcin may predict postoperative elevated parathyroid hormone in patients with primary hyperparathyroidismNahid Rianon, Gillian Alex, Glenda Callender, et al.
Thyroid : Official Journal of the American Thyroid Association|January 15, 2005
Graves' disease after interleukin-2 therapy in a patient with human immunodeficiency virus infectionCamilo Jimenez, Stephanie A Moran, Irini Sereti, et al.
Endocrine-Related Cancer|December 6, 2022
Biomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paragangliomaCamilo Jimenez, Bennett B Chin, Richard B Noto, et al.
The Journal of Clinical Endocrinology and Metabolism|November 26, 2022
TNM Staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic ParagangliomaCamilo Jimenez, Junsheng Ma, Alejandro Roman Gonzalez, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 23, 2009
Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: identification of fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein as major factors involved in tumor-induced osteomalaciaMouhammed Amir Habra, Camilo Jimenez, Su-Chen Eileen Huang, et al.
Journal of the American College of Surgeons|January 16, 2013
Long-term outcomes of surgical treatment for hereditary pheochromocytomaElizabeth G Grubbs, Thereasa A Rich, Chaan Ng, et al.
Cancer|October 19, 2011
Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experienceMontserrat Ayala-Ramirez, Lei Feng, Mouhammed A Habra, et al.
Endocrine|July 8, 2017
Phase II trial of pazopanib in advanced/progressive malignant pheochromocytoma and paragangliomaSina Jasim, Vera J Suman, Camilo Jimenez, et al.
Pageof 15

Showing results (61-70 of 146) with videos related to

Sort By:
Pageof 15
Archives of Endocrinology and Metabolism|May 25, 2021
Ectopic Cushing syndrome in ColombiaVanessa Lopez-Montoya, Johnayro Gutierrez-Restrepo, Jose Luis Torres Grajales, et al.
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|January 23, 2018
Calcitriol-mediated hypercalcemia secondary to granulomatous disease caused by soft-tissue filler injection: a case reportJairo Arturo Noreña, César Daniel Niño, Sabrina Gallego, et al.
World Journal of Surgery|January 27, 2012
Preoperative serum osteocalcin may predict postoperative elevated parathyroid hormone in patients with primary hyperparathyroidismNahid Rianon, Gillian Alex, Glenda Callender, et al.
Thyroid : Official Journal of the American Thyroid Association|January 15, 2005
Graves' disease after interleukin-2 therapy in a patient with human immunodeficiency virus infectionCamilo Jimenez, Stephanie A Moran, Irini Sereti, et al.
Endocrine-Related Cancer|December 6, 2022
Biomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paragangliomaCamilo Jimenez, Bennett B Chin, Richard B Noto, et al.
The Journal of Clinical Endocrinology and Metabolism|November 26, 2022
TNM Staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic ParagangliomaCamilo Jimenez, Junsheng Ma, Alejandro Roman Gonzalez, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 23, 2009
Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: identification of fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein as major factors involved in tumor-induced osteomalaciaMouhammed Amir Habra, Camilo Jimenez, Su-Chen Eileen Huang, et al.
Journal of the American College of Surgeons|January 16, 2013
Long-term outcomes of surgical treatment for hereditary pheochromocytomaElizabeth G Grubbs, Thereasa A Rich, Chaan Ng, et al.
Cancer|October 19, 2011
Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experienceMontserrat Ayala-Ramirez, Lei Feng, Mouhammed A Habra, et al.
Endocrine|July 8, 2017
Phase II trial of pazopanib in advanced/progressive malignant pheochromocytoma and paragangliomaSina Jasim, Vera J Suman, Camilo Jimenez, et al.
Pageof 15